Survival of patients with clinical stage IIIA non–small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors

Background In clinical stage IIIA non–small cell lung cancer, the role of surgical resection, particularly pneumonectomy, after induction therapy remains controversial. Our objective was to determine factors predictive of survival after postinduction surgical resection. Methods We retrospectively re...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Journal of thoracic and cardiovascular surgery 2011, Vol.141 (1), p.48-58
Hauptverfasser:	Paul, Subroto, MD, Mirza, Farooq, MD, Port, Jeffrey L., MD, Lee, Paul C., MD, Stiles, Brendon M., MD, Kansler, Amanda L., MPH, Altorki, Nasser K., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Aged, 80 and over Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Carcinoma, Non-Small-Cell Lung - mortality Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - therapy Cardiology. Vascular system Cardiothoracic Surgery Chemotherapy, Adjuvant Chi-Square Distribution Disease-Free Survival Female Hospital Mortality Humans Kaplan-Meier Estimate Lung Neoplasms - mortality Lung Neoplasms - pathology Lung Neoplasms - therapy Lymph Nodes - pathology Male Mediastinoscopy Medical sciences Middle Aged Neoadjuvant Therapy Neoplasm Staging Pneumology Pneumonectomy - adverse effects Pneumonectomy - mortality Proportional Hazards Models Radiotherapy, Adjuvant Retrospective Studies Risk Assessment Risk Factors Survival Rate Time Factors Treatment Outcome Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!